About

Company description

Cambrex is an innovative life sciences company that provides pharmaceutical products, expertise and technologies that accelerate small molecule therapeutics into markets across the world. With over 35 years of API development and manufacturing expertise, Cambrex is tried and trusted across branded and generic API markets.

Quick facts

Affiliated categories: API Contract Manufacturing |Bio Services |Contract Manufacturing More

Upcoming events

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany Visit us at stand 41C10 Book a meeting See our Exhibitor Profile   See full Exhibitor List
30 apr 2019

CPhI North America 2019

30 April - 2 May 2019 Chicago, USA Visit us at stand 807 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 5G12 See our Exhibitor Profile   See full Exhibitor List
24 apr 2018

CPhI North America 2018

24-26 April, 2018 Philadelphia, USA We were at stand 613 See our Exhibitor Profile   See full Exhibitor List
24 oct 2017

CPhI Worldwide 2017

24 - 26 October 2017 Messe Frankfurt, Germany We were at stand 80G40 See our Exhibitor Profile   See full Exhibitor List

Our Top products

(R) (+) 2-Amino-5-phenylpentane HCl **

(R) (+) 2-Amino-5-phenylpentane HCl **

More info
(R) 4-Cyano-methylbenzylamine **

(R) 4-Cyano-methylbenzylamine **

More info
(S) (-) 2-Amino-5-phenylpentane HCl **

(S) (-) 2-Amino-5-phenylpentane HCl **

More info
View all our products (111)

News about Cambrex

Cambrex completes acquisition of Avista Pharma Solutions

2 Jan 2019

Cambrex completes acquisition of Avista Pharma Solutions

Acquisition adds a full complement of early-stage development capabilities to Cambrex’s larger scale capabilities for APIs and finished dosage forms.

Read more

12 Dec 2018

Cambrex expands analytical capabilities

The $1 million investment will assist in getting new products to commercial launch faster.

Read more

20 Nov 2018

Acquisition boosts Cambrex's early-stage development capabilities

Acquisition adds early-stage API and finished dosage form development & testing services to its global contract development & manufacturing network.

Read more

16 Oct 2018

Cambrex invests $3m to upgrade generic API manufacturing facilities at Milan site

The investment increases the overall capacity and capabilities of the facility, and its flexibility.

Read more